FOSCARBIDOPA\FOSLEVODOPA vs FOSPHENYTOIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSCARBIDOPA\FOSLEVODOPA vs FOSPHENYTOIN: Safety Overview
| Metric | FOSCARBIDOPA\FOSLEVODOPA | FOSPHENYTOIN |
|---|---|---|
| Total FAERS Reports | 3,161 | 1,378 |
| Deaths Reported | 431 | 166 |
| Death Rate | 13.6% | 12.0% |
| Hospitalizations | 1,747 | 646 |
| Average Patient Age | 70.4 yrs | 37.5 yrs |
| % Female Patients | 42.2% | 52.4% |
| FDA Approval Date | N/A | Aug 5, 1996 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | INTRAMUSCULAR |
| Marketing Status | N/A | Prescription |